612 related articles for article (PubMed ID: 32597805)
1. Upregulation of Alzheimer's Disease Amyloid-β Protein Precursor in Astrocytes Both in vitro and in vivo.
Liang Y; Raven F; Ward JF; Zhen S; Zhang S; Sun H; Miller SJ; Choi SH; Tanzi RE; Zhang C
J Alzheimers Dis; 2020; 76(3):1071-1082. PubMed ID: 32597805
[TBL] [Abstract][Full Text] [Related]
2. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease.
Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R
Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139
[TBL] [Abstract][Full Text] [Related]
3. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.
Cai Y; Zhang XM; Macklin LN; Cai H; Luo XG; Oddo S; Laferla FM; Struble RG; Rose GM; Patrylo PR; Yan XX
Neurotox Res; 2012 Feb; 21(2):160-74. PubMed ID: 21725719
[TBL] [Abstract][Full Text] [Related]
4. Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease.
Sadleir KR; Eimer WA; Kaufman RJ; Osten P; Vassar R
PLoS One; 2014; 9(7):e101643. PubMed ID: 24992504
[TBL] [Abstract][Full Text] [Related]
5. BACE1 regulates expression of Clusterin in astrocytes for enhancing clearance of β-amyloid peptides.
Zhou J; Singh N; Galske J; Hudobenko J; Hu X; Yan R
Mol Neurodegener; 2023 May; 18(1):31. PubMed ID: 37143090
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.
Mao P; Manczak M; Calkins MJ; Truong Q; Reddy TP; Reddy AP; Shirendeb U; Lo HH; Rabinovitch PS; Reddy PH
Hum Mol Genet; 2012 Jul; 21(13):2973-90. PubMed ID: 22492996
[TBL] [Abstract][Full Text] [Related]
7. Tomoregulin (TMEFF2) Binds Alzheimer's Disease Amyloid-β (Aβ) Oligomer and AβPP and Protects Neurons from Aβ-Induced Toxicity.
Hong HS; Maezawa I; Petrlova J; Zhao XY; C Voss J; Jin LW
J Alzheimers Dis; 2015; 48(3):731-43. PubMed ID: 26402097
[TBL] [Abstract][Full Text] [Related]
8. PCP4 Promotes Alzheimer's Disease Pathogenesis by Affecting Amyloid-β Protein Precursor Processing.
Hu D; Dong X; Wang Q; Liu M; Luo S; Meng Z; Feng Z; Zhou W; Song W
J Alzheimers Dis; 2023; 94(2):737-750. PubMed ID: 37302034
[TBL] [Abstract][Full Text] [Related]
9. Localization and Trafficking of Amyloid-β Protein Precursor and Secretases: Impact on Alzheimer's Disease.
Agostinho P; Pliássova A; Oliveira CR; Cunha RA
J Alzheimers Dis; 2015; 45(2):329-47. PubMed ID: 25589722
[TBL] [Abstract][Full Text] [Related]
10. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
Kim W; Ma L; Lomoio S; Willen R; Lombardo S; Dong J; Haydon PG; Tesco G
Mol Neurodegener; 2018 Feb; 13(1):6. PubMed ID: 29391027
[TBL] [Abstract][Full Text] [Related]
11. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice.
Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B
J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413
[TBL] [Abstract][Full Text] [Related]
13. Divergent Age-Dependent Conformational Rearrangement within Aβ Amyloid Deposits in APP23, APPPS1, and
Parvin F; Haglund S; Wegenast-Braun B; Jucker M; Saito T; Saido TC; Nilsson KPR; Nilsson P; Nyström S; Hammarström P
ACS Chem Neurosci; 2024 May; 15(10):2058-2069. PubMed ID: 38652895
[TBL] [Abstract][Full Text] [Related]
14. AQP4 Association with Amyloid Deposition and Astrocyte Pathology in the Tg-ArcSwe Mouse Model of Alzheimer's Disease.
Yang J; Zhang R; Shi C; Mao C; Yang Z; Suo Z; Torp R; Xu Y
J Alzheimers Dis; 2017; 57(1):157-169. PubMed ID: 28222512
[TBL] [Abstract][Full Text] [Related]
15. Astrocytes from old Alzheimer's disease mice are impaired in Aβ uptake and in neuroprotection.
Iram T; Trudler D; Kain D; Kanner S; Galron R; Vassar R; Barzilai A; Blinder P; Fishelson Z; Frenkel D
Neurobiol Dis; 2016 Dec; 96():84-94. PubMed ID: 27544484
[TBL] [Abstract][Full Text] [Related]
16. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis.
Mahan TE; Wang C; Bao X; Choudhury A; Ulrich JD; Holtzman DM
Mol Neurodegener; 2022 Feb; 17(1):13. PubMed ID: 35109920
[TBL] [Abstract][Full Text] [Related]
17. Neuronally Derived Soluble Abeta Evokes Cell-Wide Astrocytic Calcium Dysregulation in Absence of Amyloid Plaques
Kelly P; Sanchez-Mico MV; Hou SS; Whiteman S; Russ A; Hudry E; Arbel-Ornath M; Greenberg SM; Bacskai BJ
J Neurosci; 2023 Jun; 43(26):4926-4940. PubMed ID: 37236808
[TBL] [Abstract][Full Text] [Related]
18. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
[TBL] [Abstract][Full Text] [Related]
19. Regulation of AβPP Glycosylation Modification and Roles of Glycosylation on AβPP Cleavage in Alzheimer's Disease.
Tao PF; Huang HC
ACS Chem Neurosci; 2019 May; 10(5):2115-2124. PubMed ID: 30802027
[TBL] [Abstract][Full Text] [Related]
20. Increased Foxo3a Nuclear Translocation and Activity is an Early Neuronal Response to βγ-Secretase-Mediated Processing of the Amyloid-β Protein Precursor: Utility of an AβPP-GAL4 Reporter Assay.
Law BM; Guest AL; Pullen MWJ; Perkinton MS; Williams RJ
J Alzheimers Dis; 2018; 61(2):673-688. PubMed ID: 29254083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]